Phase II Request definition

Phase II Request shall have the meaning given that term in Section 5.01(b).
Sample 1Sample 2
Phase II Request is defined in Section 6.2(b).
Sample 1

Examples of Phase II Request in a sentence

  • The exchange procurement’s Phase II Request for Proposals stated:As part of this procurement, Offerors are required, among other things, to establish the credit they will contribute toward the cost of the consolidated FBI Headquarters in exchange for JEH.

  • If the federal Interagency Working Group publishes updates that either recommend using a lower discount rate for the SCC, or that recommend higher values for the SCC prior to the issuance of the Phase II Request for Proposals (“RFP”), the Company will use the updated discount rate and updated values.

  • Massachusetts Department of Transportation, (MassDOT), Longfellow Bridge Rehabilitation Phase II Request for Proposals, Boston, Massachusetts, 2012, p.

  • Seller may, in its sole discretion, approve or deny any Phase II Request, in whole or in part, and Buyer shall not have the right to conduct any activities identified in such Phase II Request unless and until such time that Seller has approved such Phase II Request in writing.

  • Duke’s Phase II Request is unnecessary to meet the goals of EO 80, and if approved as proposed would give Duke a substantial portion of the marketplace, which the Commission wanted to avoid when approving Phase I.

  • On July 7, 2021, the North Carolina Sustainable Energy Association filed a Motion for Extension of Time to file comments on the Phase II Request, which the Commission granted on July 8, 2021.

  • The Public Staff also believes that the Phase II Request may ultimately prove be unnecessary considering current EV adoption trends, Tesla’s announcement to open its fast chargers will be open to other types of vehicles in 2021,1 and the amount of capital likely to be invested in the market from other sources.

  • Each Phase II Request will state with reasonable specificity (i) the actual or potential “recognized environmental conditions” or findings identified, (ii) the proposed scope of the Phase II Assessment, including a description of the activities to be conducted, and a description of the approximate location and expected timing of such activities, and (iii) the Assets that are affected by the identified “recognized environmental conditions” or findings noted in such Phase II Request.

  • The Phase II Request for Proposal is for the engineering of the Landslide Dewatering and Stabilization Project for the storm damaged portion of Amesti Road between Crow Avenue and Browns Valley Road.

  • Duke does not state in the Phase II Request if the Companies have attempted to obtain partnerships that could help cover the cost of the infrastructure, if they plan to do so in the future, or explain why doing so would not be beneficial to customers of these pilot programs.Timing Issues The Public Staff also opposes the Phase II Request because the prevailing trends in the EV market appear to suggest that these programs are unnecessary at this time, especially at the levels Duke is requesting.

Related to Phase II Request

  • L/C Request has the meaning specified in Section 2.4(b).

  • Phase II Study means a study in humans of the safety, dose ranging or efficacy of a product, as further defined in 21 C.F.R. § 312.21(b) (or the equivalent thereof outside the United States).

  • Draw Request Any request by the Borrower, pursuant to Section 2.2 of this Agreement, for a disbursement of any portion of the proceeds of the Loan.

  • Commercial use request means a re- quest from or on behalf of one who seeks information for a use or purpose that furthers the commercial, trade, or profit interests of the requester or the person on whose behalf the request is made.

  • Advance Request means a request for an Advance submitted by Borrower to Lender in substantially the form of Exhibit A.

  • Access Request means a request for access to Facilities and/or Services on the Access List made by the Access Seeker under subsection 5.4.5 of the MSA Determination and containing the information in subsection 5.4.6 of the MSA Determination and in Clause 5(b) hereof and as per the format in Appendix A hereof.

  • Work request means a document prepared by the Contractor which describes over and above work being proposed.

  • Disbursement Request means a disbursement request from the Borrower to the Administrative Agent and the Collateral Agent in the form attached hereto as Exhibit C in connection with a disbursement request from the Unfunded Exposure Account in accordance with Section 2.04(d) or a disbursement request from the Principal Collection Subaccount in accordance with Section 2.18, as applicable.

  • Urgent care request means a claim relating to an admission, availability of care, continued stay or health care service for which the covered person received emergency services but has not been discharged from a facility, or any Pre-Service Claim or concurrent care claim for medical care or treatment for which application of the time periods for making a regular external review determination:

  • Release Request has the meaning set forth in Section 2.1.

  • Phase II Trial means a clinical trial of a Licensed Product on patients, including possibly pharmacokinetic and dose ranging studies, the principal purposes of which are to make a preliminary determination that such Licensed Product is safe for its intended use and to obtain sufficient information about such Licensed Product’s efficacy to permit the design of further clinical trials, and generally consistent with 21 CFR §312.21(b), or its successor regulation, or the equivalent in any foreign country.

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).

  • Phase I Report means, with respect to any Facility, a report that (i) conforms to the ASTM Standard Practice for Environmental Site Assessments: Phase I Environmental Site Assessment Process, E 1527, (ii) was conducted no more than six months prior to the date such report is required to be delivered hereunder, by one or more environmental consulting firms reasonably satisfactory to Administrative Agent, (iii) includes an assessment of asbestos-containing materials at such Facility, (iv) is accompanied by (a) an estimate of the reasonable worst-case cost of investigating and remediating any Hazardous Materials Activity identified in the Phase I Report as giving rise to an actual or potential material violation of any Environmental Law or as presenting a material risk of giving rise to a material Environmental Claim, and (b) a current compliance audit setting forth an assessment of Holdings’, its Subsidiaries’ and such Facility’s current and past compliance with Environmental Laws and an estimate of the cost of rectifying any non-compliance with current Environmental Laws identified therein and the cost of compliance with reasonably anticipated future Environmental Laws identified therein.

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Change Order Request means a written request or proposal for a Change Order submitted by either Company or Contractor and including:

  • Subject Access Request means a request for Personal Data falling within the provisions of Section 7 of the DPA and Article 11, 12 & 15 of the GDPR

  • Phase III means human clinical trials, the principal purpose of which is to establish substantial evidence of both safety and efficacy in patients with the disease or condition being studied, as more fully defined in 21 C.F.R. §312.21(c) or similar clinical study in a country other than the United States. Phase III shall also include any other human clinical trial intended to serve as a pivotal trial to support the submission of an application for regulatory approval.

  • Phase III Study means a human clinical trial that is prospectively designed to demonstrate statistically whether a product is safe and effective for use in humans in a manner sufficient to obtain regulatory approval to market such product in patients having the disease or condition being studied as described in 21 C.F.R. § 312.21(c) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • Completion Notice means a notice issued by the Developer in accordance with clause 6.1.

  • Funding Request shall have the meaning set forth in Section 5.3(a).

  • Final completion and acceptance means the stage in the progress of the work as determined by the Contracting Officer and confirmed in writing to the Contractor, at which all work required under the contract has been completed in a satisfactory manner, subject to the discovery of defects after final completion, and except for items specifically excluded in the notice of final acceptance.

  • improvement notice means the notice issued by the Authority to the Supplier pursuant to Clause 32.1.3 (Authority Remedies) which will detail how the Supplier shall improve the provision of the Goods and/or Services;

  • Phase II means the second part of the tuition incentive assistance program which provides assistance in the third and fourth year of 4-year degree programs.

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Phase I Trial means a clinical trial of a Licensed Product in human patients conducted primarily for the purpose of determining the safety, tolerability and preliminary activity of the Licensed Product, including, without limitation, for determining the maximum tolerated dose, or optimal dose. For purposes of this Agreement, a Phase I trial shall specifically exclude a study in healthy volunteers.